• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

密歇根州新生儿免疫反应性胰蛋白酶原浓度的差异及其对囊性纤维化新生儿筛查的影响。

Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.

机构信息

Michigan Department of Community Health, Lansing, MI 48906, USA.

出版信息

Pediatr Pulmonol. 2011 Feb;46(2):125-30. doi: 10.1002/ppul.21330. Epub 2010 Sep 16.

DOI:10.1002/ppul.21330
PMID:20848586
Abstract

OBJECTIVE

To investigate variation in immunoreactive trypsinogen (IRT) concentrations by race, sex, birth weight, and gestational age and their implications for the use of percentile-based cutoffs for cystic fibrosis (CF) newborn screening (NBS) programs.

PATIENTS AND METHODS

This cross-sectional population-based study of resident infants screened in Michigan investigates associations between demographic and perinatal variables and IRT concentrations after controlling for covariates. This study also analyzed how 96th and 99.8th IRT concentration percentiles values calculated by Michigan NBS vary by demographic and perinatal factors. Characteristics of infants having high (≥99.8th percentile) IRT concentrations and negative DNA tests are also explored.

RESULTS

IRT mean concentrations and percentiles vary significantly by race, birth weight, gestational age, and to a lesser degree by sex. The greatest variation in mean IRT concentrations was observed among racial categories; black infants had an adjusted mean concentration of 36 ng/ml and Asian/Pacific Islander infants had a mean concentration of 25 ng/ml compared to an average concentration of 28 ng/ml in white infants and infants of other races.

CONCLUSIONS

Variation in IRT concentrations resulted in the over-representation of certain groups referred for secondary testing, particularly referrals for sweat testing based on very high (≥99.8th percentile) concentrations alone, which is no longer recommended in Michigan. Further research may be warranted to evaluate initial IRT cutoffs used for CF NBS.

摘要

目的

研究种族、性别、出生体重和胎龄对免疫反应性胰蛋白酶原 (IRT) 浓度的变化及其对基于百分位的囊性纤维化 (CF) 新生儿筛查 (NBS) 方案的影响。

方法

这项对密歇根州筛查的常住婴儿进行的横断面人群研究调查了人口统计学和围产期变量与 IRT 浓度之间的关联,同时控制了协变量。本研究还分析了密歇根州 NBS 计算的第 96 百分位和第 99.8 百分位 IRT 浓度值如何因人口统计学和围产期因素而变化。还探讨了具有高 (≥99.8 百分位) IRT 浓度和阴性 DNA 检测的婴儿的特征。

结果

IRT 平均浓度和百分位值因种族、出生体重、胎龄而有显著差异,在一定程度上也因性别而异。IRT 浓度的平均差异最大的是种族类别;与白种婴儿平均浓度 28ng/ml 相比,黑种婴儿的调整后平均浓度为 36ng/ml,亚洲/太平洋岛民婴儿的平均浓度为 25ng/ml。

结论

IRT 浓度的变化导致某些群体被过度推荐进行二次检测,特别是仅根据非常高 (≥99.8 百分位) 浓度进行汗试验推荐,这在密歇根州已不再推荐。可能需要进一步研究来评估用于 CF NBS 的初始 IRT 截止值。

相似文献

1
Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.密歇根州新生儿免疫反应性胰蛋白酶原浓度的差异及其对囊性纤维化新生儿筛查的影响。
Pediatr Pulmonol. 2011 Feb;46(2):125-30. doi: 10.1002/ppul.21330. Epub 2010 Sep 16.
2
Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.通过对免疫反应性胰蛋白酶原的初步分析,阐明影响囊性纤维化新生儿筛查的实验室和临床变量。
Pediatrics. 2009 Feb;123(2):e338-46. doi: 10.1542/peds.2008-1681.
3
Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.科罗拉多州基于两层免疫反应性胰蛋白酶原的囊性纤维化新生儿筛查:筛查效果与诊断结果
J Pediatr. 2005 Sep;147(3 Suppl):S83-8. doi: 10.1016/j.jpeds.2005.08.005.
4
Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.威斯康星州囊性纤维化新生儿筛查:九年常规胰蛋白酶原/DNA检测经验
J Pediatr. 2005 Sep;147(3 Suppl):S73-7. doi: 10.1016/j.jpeds.2005.08.004.
5
A survey of newborn screening for cystic fibrosis in Europe.欧洲囊性纤维化新生儿筛查调查。
J Cyst Fibros. 2007 Jan;6(1):57-65. doi: 10.1016/j.jcf.2006.05.008. Epub 2006 Jul 25.
6
Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis.结合免疫反应性胰蛋白酶原和胰腺炎相关蛋白检测,一种避免DNA分析的新生儿囊性纤维化筛查方法。
J Pediatr. 2005 Sep;147(3):302-5. doi: 10.1016/j.jpeds.2005.05.017.
7
Predictors of insufficient sweat production during confirmatory testing for cystic fibrosis.囊性纤维化确诊试验中汗液分泌不足的预测因素。
Pediatr Pulmonol. 2011 Jan;46(1):23-30. doi: 10.1002/ppul.21318. Epub 2010 Sep 1.
8
Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.免疫反应性胰蛋白酶原/DNA囊性纤维化新生儿筛查算法导致的诊断困境
J Pediatr. 2005 Sep;147(3 Suppl):S78-82. doi: 10.1016/j.jpeds.2005.08.017.
9
Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.通过检测胰蛋白酶原浓度进行全州范围内囊性纤维化新生儿筛查的效果。
N Engl J Med. 1991 Sep 12;325(11):769-74. doi: 10.1056/NEJM199109123251104.
10
Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations.比较三种中欧人群中不同的 IRT-PAP 方案用于新生儿囊性纤维化的筛查。
J Cyst Fibros. 2014 Jan;13(1):15-23. doi: 10.1016/j.jcf.2013.06.003. Epub 2013 Jul 25.

引用本文的文献

1
Cystic Fibrosis Newborn Screening: A Systematic Review-Driven Consensus Guideline from the United States Cystic Fibrosis Foundation.囊性纤维化新生儿筛查:来自美国囊性纤维化基金会的一项基于系统评价的共识指南。
Int J Neonatal Screen. 2025 Apr 2;11(2):24. doi: 10.3390/ijns11020024.
2
Cystic Fibrosis Screening Efficacy and Seasonal Variation in California: 15-Year Comparison of IRT Cutoffs Versus Daily Percentile for First-Tier Testing.加利福尼亚州囊性纤维化筛查的效果及季节性变化:15年IRT临界值与一线检测每日百分位数的比较
Int J Neonatal Screen. 2024 Nov 22;10(4):76. doi: 10.3390/ijns10040076.
3
CFTR gene variants, air pollution, and childhood asthma in a California Medicaid population.
CFTR 基因突变、空气污染与加利福尼亚医疗补助人群中的儿童哮喘。
Pediatr Pulmonol. 2022 Nov;57(11):2798-2807. doi: 10.1002/ppul.26103. Epub 2022 Aug 17.
4
Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis.构建用于评估和优化新生儿囊性纤维化血斑筛查的生物伦理框架。
Int J Neonatal Screen. 2020 May 26;6(2):40. doi: 10.3390/ijns6020040. eCollection 2020 Jun.
5
Trends in Scottish newborn screening programme for congenital hypothyroidism 1980-2014: strategies for reducing age at notification after initial and repeat sampling.1980 - 2014年苏格兰先天性甲状腺功能减退症新生儿筛查项目趋势:初次和重复采样后降低通知年龄的策略
Arch Dis Child. 2017 Oct;102(10):936-941. doi: 10.1136/archdischild-2016-312156. Epub 2017 Jun 9.
6
Improving the Rate of Sufficient Sweat Collected in Infants Referred for Sweat Testing in Michigan.提高密歇根州因进行汗液检测而转诊的婴儿足够汗液采集率。
Glob Pediatr Health. 2014 Oct 9;1:2333794X14553625. doi: 10.1177/2333794X14553625. eCollection 2014.
7
Screening for cystic fibrosis in New York State: considerations for algorithm improvements.纽约州囊性纤维化的筛查:算法改进的考量因素
Eur J Pediatr. 2016 Feb;175(2):181-93. doi: 10.1007/s00431-015-2616-3. Epub 2015 Aug 21.
8
Newborn screening and diagnosis of mucopolysaccharidoses.新生儿筛查与黏多糖贮积症的诊断。
Mol Genet Metab. 2013 Sep-Oct;110(1-2):42-53. doi: 10.1016/j.ymgme.2013.06.007. Epub 2013 Jun 21.
9
Effects of immediate telephone follow-up with providers on sweat chloride test timing after cystic fibrosis newborn screening identifies a single mutation.在囊性纤维化新生儿筛查后,通过与提供者进行即时电话随访对氯汗液测试时间的影响可识别出单一突变。
J Pediatr. 2013 Mar;162(3):522-9. doi: 10.1016/j.jpeds.2012.08.055. Epub 2012 Oct 24.